Surmodics (SRDX)
(Delayed Data from NSDQ)
$41.55 USD
-0.26 (-0.62%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $41.50 -0.05 (-0.12%) 7:58 PM ET
1-Strong Buy of 5 1
D Value F Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Surmodics, Inc. [SRDX]
Reports for Purchase
Showing records 361 - 380 ( 418 total )
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Q1 ?12 in line with expectations; reducing to HOLD with a target price of $15
Provider: FELTL & COMPANY
Analyst: ANDBERG E
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
SRDX Restructuring completed and turnaround unfolding, raising target price to $14.15
Provider: FELTL & COMPANY
Analyst: ANDBERG E
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
SRDX Q4a??11 revenues in line, Pharma business sold, growth in revenue and profit expected
Provider: FELTL & COMPANY
Analyst: ANDBERG E
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Q3?11 shows surprisingly strong results in the Pharma business
Provider: FELTL & COMPANY
Analyst: ANDBERG E
Company: Surmodics, Inc.
Industry: Medical - Products
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.